PharmExec Picks: Having trouble viewing this e-mail? Click here.

Update My Profile | Advertise With Us | Visit PharmExec.com | SUBSCRIBE Pharm Exec Picks is a biweekly eletter that delivers the most popular news and articles from the pharma space and highlights what’s trending on social media. Top 5 Stories : Express Scripts 2020: Back to the Future? Having achieved formidable “size and scale,” how will the nation's largest pharmacy benefit manager synchronize with value-based health care? Read more     The Pathway to Public Rx Price Controls in 2016 The issue of drug price controls in public prescription programs has long been a point of contention. But today... we may be on a pathway to changing that. Read more     Syncing Personalized Medicine and Marketing The new generation of individualized treatments will require life sciences companies to evolve how they reach and educate the healthcare community. Matt Wallach asks, are your commercial operations up to the task? Read more     Pharma's Prescription for Social ROI Peter Friedman discusses five ways brand teams can find value in social media programs. Read more China: Present for the Journey For big Pharma, disciplined commitment to local engagement in China begins with a strong government affairs (GA) organization managed by top local talent. Here are five steps to building a world-class GA function in China. Read more   Follow Us   Trending on Social Media : Biotech Positioning for Boom Times and Beyond Pharm Exec sits down with prominent biotech investment strategist, Tony Gibney, to better gauge today's state of play in this critically innovative segment of the life sciences industry. Read more Mylan Commences Formal Offer to Acquire Perrigo Mylan (Canonsburg, PA) has officially commenced its formal offer to acquire all outstanding ordinary shares of Perrigo (Dublin, Ireland). Read more India Reports Surge in Pharma Market The India Brand Equity Foundation (IBEF) reports that the Indian domestic pharma market is estimated at INR 90,400 crore (US$ 15 bn), ending FY15 with a growth of 12%. Read more